Stem Cells as a Promising Treatment of Diabetes

An Overview

A study by the International Diabetes Federation in 2021 revealed that approximately 537 million adults (20-79 years) are living with diabetes. Researchers have found a potential cure to treat Type 1 and Type 2 Diabetes through an innovative method of stem cell therapy. Dr. David Greene's R3 Stem Cell is one of the leading centers that have excelled in treating diabetic patients with stem cell therapy.

Stem cells can differentiate into different types of cells in the body, making them a prime candidate to combat the condition affecting millions. In this article, we will be covering.

• What is Diabetes? How is it Treated?
• What is Stem Cell Research?
• What is R3 Stem Cell Therapy?
• Is Dr. David Greene’s R3 Stem Cell a Potential Cure?
• Takeaway

What Is Diabetes? How Is It Treated?

Diabetes is an umbrella term for diseases where the body cannot produce or use insulin, the hormone helping food convert into energy. An estimated 37.3 million people (11.3% of the US population) have diabetes, and 8.5 million people (23%) are unaware and undiagnosed.

There are three many types of diabetes:

• - Type 1: Auto-immune disease
• - Type 2: Hereditary and Lifestyle factors
• - Gestational Diabetes- Occurs during pregnancy

In simpler words, diabetes causes blood sugar to elevate because the pancreas does not produce enough insulin (Type 1). Or because cells in the body fail to respond to the insulin released (Type 2).

Type 1 Diabetes

Previously known as Juvenile Diabetes, the body's immune system attacks the beta cells in the pancreas. As a result, they lead to insufficient insulin for properly controlling glucose levels. As a result, high sugar levels cause damage to the kidneys, eyes, and nervous system.

Type 2 Diabetes

Previously known as Adult-Onset Diabetes, cells resist insulin released by beta cells. Thereby, beta cells produce more insulin to signal other cells. Genetic background and lack of exercise are the main factors that cause this disease.

What is Stem Cell Research?

Stem cells are a form of cell that is yet to develop a specific set of traits. And the research covers the scientific study of these stem cells. Nevertheless, the research has opened up a broad spectrum of possibilities to cure diabetes.

Stem cells are used for ongoing research to help explore ways our bodies process sugar and answer questions about the root cause of diabetes.

In type 1 diabetes, why does the immune system only attack beta cells and not other cells in the pancreas, organs, or tissues?

In type 2 diabetes, what causes insulin resistance?

Recently, tremendous progress has been observed in generating beta cells from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPS).

What is R3 Stem Cell Therapy? Is Dr. David Greene’s R3 Stem

Cell a Potential Cure?

The retired orthopedic surgeon David Greene founded R3 Stem Cell, offering cutting-edge regenerative medicine therapies. Dr. David Greene’s R3 Stem Cell Centers of Excellence are staffed with experienced and compassionate providers. Treatments include bone marrow, adipose, amniotic, PRP, and umbilical cord tissue.

R3 Stem Cell To Cure Type 1 Diabetes

Characterized by the body’s inability to produce insulin; therefore, it necessitates daily injections of insulin. Although the researchers and experts of R3 Stem Cells haven’t found a complete cure, proven cases of patients without insulin injection use are observed.

Researchers have been using stem cells to create insulin-producing islets in the pancreas. Stem cell replacements are more than swapping insulin-producing cells with those destroyed by diabetes. Islet cell transplants are one proven effective form discovered.

David Greene, Orthopedic Surgeon, Aims To Cure Type 2 Diabetes

In 2017, researchers analyzed studies published between 2006 to 2016, comprising 342 patients who received stem cell therapy. While not everyone responded to the treatment, improved glucose control and reduced insulin dependency were observed.

Takeaway

R3 Stem Cell aims to deliver effective and safe regenerative therapies in the United States & internationally. David Greene's philosophy of R3 entails providing clinically effective, secure, and cost-effective treatments worldwide.

In terms of relationship with the patients, David Greene states,

"When it comes to faith, our outcomes speak for themselves. Our patient satisfaction rate has been 85%, and our treatments are 35$ patient referral-based."